Brave Asset Management Inc T2 Biosystems, Inc. Transaction History

Brave Asset Management Inc

  • $410 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 02, 2021
BUY
$0.86 - $1.21 $6,101 - $8,584
7,095 Added 36.75%
26,400 $24,000
Q2 2021

Jul 27, 2021
BUY
$1.04 - $1.69 $20,077 - $32,625
19,305 New
19,305 $23,000

About T2 Biosystems, Inc.

TTOO Quotes by TradingView
  • Ticker TTOO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 7,050,850
  • Market Cap $3.88M
  • Description
  • T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...
More about TTOO
Track This Portfolio

Track Brave Asset Management Inc Portfolio

Follow Brave Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brave Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brave Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email